Taiwan FDA registration c3c5031ccf41ece27864ddac0bda6ad6
HMD Well Blood Glucose Monitoring System
TW: 厚美德金健康血糖檢測系統
Taiwan·Risk Class 2·MD·HMD BIOMEDICAL INC.·Registered Nov 23, 2018 – Jun 20, 2026ExpiredRegistration details
- Analysis ID
- c3c5031ccf41ece27864ddac0bda6ad6
- License Form
- Ministry of Health Medical Device Manufacturing No. 006268
Company information
- Manufacturer
- HMD BIOMEDICAL INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- HMD BIOMEDICAL INC.
Product details
- Intended Use
- This product is made using electrochemical biosensing technology, and can only be used in combination with Houmei Dejin Health Blood Glucose Test Piece, providing diabetic patients with home detection of microvascular whole blood glucose value. And under the operation of professional nursing staff in the hospital, the blood glucose values of adult microvascular, venous blood and neonatal whole blood can be detected.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Nov 23, 2018
- Expiry Date
- Jun 20, 2026
About this record
Access comprehensive regulatory information for HMD Well Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c3c5031ccf41ece27864ddac0bda6ad6 and manufactured by HMD BIOMEDICAL INC.. The authorized representative in Taiwan is HMD BIOMEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices